Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

PSA can help diagnose high androgen levels in women.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Certain natural compounds called terpenes may help prevent prostate cancer.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Certain drugs that block specific enzymes can help treat prostate diseases.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.